FDA calendar · February 2020 · built from SEC filings

PDUFA dates February 2020: FDA calendar and catalysts.

Updated Snapshot 20261116T112050ZBuilt

0 PDUFA dates fell in February 2020. The FDA calendar also recorded 8 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.

PDUFA dates in February 2020

No PDUFA dates are disclosed for this period as of November 16, 2026.

Download: CSV · JSON · iCal (next 30 days, CC BY 4.0) · Calendar API · All months

February 2020: other FDA decisions and filings

DateDrugCompanyEventIndicationStatusSource
February 4, 2020Vemlidy (tenofovir alafenamide fumarate)GILDLabel expansion—ApprovedopenFDA Drugs@FDA
February 5, 2020Tecfidera (dimethyl fumarate)BIIBLabel expansion—ApprovedopenFDA Drugs@FDA
February 14, 2020Pataday Twice Daily Relief (olopatadine hydrochloride)ALCLabel expansion—ApprovedopenFDA Drugs@FDA
February 14, 2020Voltaren Arthritis Pain (diclofenac sodium)HLNLabel expansion—ApprovedopenFDA Drugs@FDA
February 21, 2020Trulicity (dulaglutide)LLYLabel expansion—ApprovedopenFDA Drugs@FDA
February 25, 2020Nerlynx (neratinib maleate)PBYILabel expansion—ApprovedopenFDA Drugs@FDA
February 27, 2020Nurtec Odt (rimegepant sulfate)PFEFDA approval—ApprovedopenFDA Drugs@FDA
February 28, 2020Advil Dual Action With Acetaminophen (acetaminophen; ibuprofen)HLNFDA approval—ApprovedopenFDA Drugs@FDA

February 2020: dated readouts

No events in this view.

Questions

What PDUFA dates are in February 2020?

0 PDUFA dates fell in February 2020. The FDA calendar also recorded 8 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.

Can these dates change?

Yes. The FDA can extend a review by three months after a major amendment, and it sometimes acts before the goal date. Each row links the filing the date came from.

Built from primary public sources only: sponsor SEC filings (8-K, EX-99.1, 10-Q, 10-K), the FDA advisory committee calendar, FDA Novel Drug Approvals and Complete Response Letter records, openFDA, and ClinicalTrials.gov (U.S. National Library of Medicine). Every row links the sentence it came from. Dates move; the linked source is authoritative. Not investment or medical advice.

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.